Literature DB >> 15044390

Structural characterization of the bovine tracheal chondroitin sulfate chains and binding of Plasmodium falciparum-infected erythrocytes.

Arivalagan Muthusamy1, Rajeshwara N Achur, Manojkumar Valiyaveettil, Subbarao V Madhunapantula, Ikuko Kakizaki, Veer P Bhavanandan, Channe D Gowda.   

Abstract

Sequestration of Plasmodium falciparum-infected red blood cells (IRBCs) in the human placenta is mediated by chondroitin 4-sulfate (C4S). A cytoadherence assay using chondroitin sulfate proteoglycans (CSPGs) is widely used for studying C4S-IRBC interactions. Bovine tracheal chondroitin sulfate A (CSA) preparation lacking a major portion of core protein has been frequently used for the assay. Here the CSPG purified from bovine trachea and CSA were assessed for IRBC binding and the CS chains studied in detail for structure-activity relationship. The IRBCs bound at significantly higher density to the CSPG than CSA. The CS chains of CSPG/CSA are heterogeneous with varying levels of 4- and 6-sulfates, which are distributed such that approximately 80% of the 4-sulfated disaccharides are present as single and blocks of two or three separated by one to three 6-sulfated disaccharides. The remainder of the 4-sulfated disaccharides is present in blocks composed of 4-12 units, separated by 6-sulfated disaccharides. In the IRBC adherence inhibition analysis, CSA fragments with 88%-92% 4-sulfate were significantly less inhibitory than the intact CSA, indicating that the regions consisting of shorter 4-sulfated blocks efficiently bind IRBCs despite the presence of relatively high levels of 6-sulfate. This is because the 6-sulfated disaccharides have unsubstituted C-4 hydroxyls that are crucial for IRBC binding. The presence of high levels of 6-sulfate, however, significantly interfere with the IRBC binding activity of CSA, which otherwise would more efficiently bind IRBCs. Thus our study revealed the distribution pattern of 4- and 6-sulfate in bovine tracheal CSA and structural basis for IRBC binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044390     DOI: 10.1093/glycob/cwh077

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  10 in total

1.  Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression.

Authors:  Arivalagan Muthusamy; Rajeshwara N Achur; Manojkumar Valiyaveettil; John J Botti; Diane W Taylor; Rose F Leke; D Channe Gowda
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

2.  The human gut microbe Bacteroides thetaiotaomicron encodes the founding member of a novel glycosaminoglycan-degrading polysaccharide lyase family PL29.

Authors:  Didier Ndeh; Jose Munoz Munoz; Alan Cartmell; David Bulmer; Corinne Wills; Bernard Henrissat; Joseph Gray
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

3.  Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharides.

Authors:  Vitor H Pomin; Younghee Park; Rongrong Huang; Christian Heiss; Joshua S Sharp; Parastoo Azadi; James H Prestegard
Journal:  Glycobiology       Date:  2012-02-17       Impact factor: 4.313

4.  Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.

Authors:  Arivalagan Muthusamy; Carlton R Cooper; Ronald R Gomes
Journal:  BMC Biochem       Date:  2010-11-03       Impact factor: 4.059

5.  Binding affinity of Plasmodium falciparum-infected erythrocytes from infected placentas and laboratory selected strains to chondroitin 4-sulfate.

Authors:  Rajeshwara N Achur; Arivalagan Muthusamy; SubbaRao V Madhunapantula; D Channe Gowda
Journal:  Mol Biochem Parasitol       Date:  2008-02-14       Impact factor: 1.759

6.  Plasmodium falciparum: Assessment of parasite-infected red blood cell binding to placental chondroitin proteoglycan and bovine tracheal chondroitin sulfate A.

Authors:  Atul Goyal; Suchi Goel; D Channe Gowda
Journal:  Exp Parasitol       Date:  2009-06-07       Impact factor: 2.011

7.  The effect of substitution of the N-acetyl groups of N-acetylgalactosamine residues in chondroitin sulfate on its degradation by chondroitinase ABC.

Authors:  Subbarao V Madhunapantula; Rajeshwara N Achur; Veer P Bhavanandan; D Channe Gowda
Journal:  Glycoconj J       Date:  2007-05-29       Impact factor: 2.916

8.  How specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?

Authors:  Suchi Goel; D Channe Gowda
Journal:  Trends Parasitol       Date:  2011-04-18

9.  Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A.

Authors:  Kavita Singh; Apostolos G Gittis; Phuc Nguyen; D Channe Gowda; Louis H Miller; David N Garboczi
Journal:  Nat Struct Mol Biol       Date:  2008-09       Impact factor: 15.369

10.  Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development.

Authors:  Arnaud Chêne; Stéphane Gangnard; Célia Dechavanne; Sebastien Dechavanne; Anand Srivastava; Marilou Tétard; Sophia Hundt; Odile Leroy; Nicolas Havelange; Nicola K Viebig; Benoît Gamain
Journal:  NPJ Vaccines       Date:  2018-07-17       Impact factor: 7.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.